BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Li J, Wang F, Zhang HJ, Sheng JQ, Yan WF, Ma MX, Fan RY, Gu F, Li CF, Chen DF, Zheng P, Gu YP, Cao Q, Yang H, Qian JM, Hu PJ, Xia B. Corticosteroid therapy in ulcerative colitis: Clinical response and predictors. World J Gastroenterol 2015; 21(10): 3005-3015 [PMID: 25780299 DOI: 10.3748/wjg.v21.i10.3005]
URL: https://www.wjgnet.com/1007-9327/full/v21/i10/3005.htm
Number Citing Articles
1
Zhaobei Cai, Shu Wang, Jiannan Li. Treatment of Inflammatory Bowel Disease: A Comprehensive ReviewFrontiers in Medicine 2021; 8 doi: 10.3389/fmed.2021.765474
2
Sophie Vieujean, Edouard Louis. Precision medicine and drug optimization in adult inflammatory bowel disease patientsTherapeutic Advances in Gastroenterology 2023; 16: 175628482311733 doi: 10.1177/17562848231173331
3
Cristina Ribeiro de Barros Cardoso, Amanda de Castro Habka, Camila Figueiredo Pinzan, Camilla Narjara Simão Oliveira, Jefferson Luiz da Silva, Murillo Duarte-Silva. Biological Therapy for Inflammatory Bowel Disease2020;  doi: 10.5772/intechopen.90009
4
Zhen-Huan Yang, Fang Liu, Xiao-Ran Zhu, Fei-Ya Suo, Zi-jun Jia, Shu-Kun Yao. Altered profiles of fecal bile acids correlate with gut microbiota and inflammatory responses in patients with ulcerative colitisWorld Journal of Gastroenterology 2021; 27(24): 3609-3629 doi: 10.3748/wjg.v27.i24.3609
5
Mona A. Mohammed, Bassant M. M. Ibrahim, Yasmin Abdel-Latif, Azza H. Hassan, Mohamed A. El Raey, Emad M. Hassan, Souad E. El-Gengaihi. Pharmacological and metabolomic profiles of Musa acuminata wastes as a new potential source of anti-ulcerative colitis agentsScientific Reports 2022; 12(1) doi: 10.1038/s41598-022-14599-8
6
Kate E. Lee, Adam S. Faye, Séverine Vermeire, Bo Shen. Perioperative Management of Ulcerative Colitis: A Systematic ReviewDiseases of the Colon & Rectum 2022; 65(S1): S5 doi: 10.1097/DCR.0000000000002588
7
Fan Wang, Xue Lin, Qiu Zhao, Jin Li. Fat intake and risk of ulcerative colitis: Systematic review and dose–response meta‐analysis of epidemiological studiesJournal of Gastroenterology and Hepatology 2017; 32(1): 19 doi: 10.1111/jgh.13416
8
Heike E. F. Becker, Karlijn Demers, Luc J. J. Derijks, Daisy M. A. E. Jonkers, John Penders. Current evidence and clinical relevance of drug-microbiota interactions in inflammatory bowel diseaseFrontiers in Microbiology 2023; 14 doi: 10.3389/fmicb.2023.1107976
9
Duaa Ahmed Elhag, Manoj Kumar, Marwa Saadaoui, Anthony K. Akobeng, Fatma Al-Mudahka, Mamoun Elawad, Souhaila Al Khodor. Inflammatory Bowel Disease Treatments and Predictive Biomarkers of Therapeutic ResponseInternational Journal of Molecular Sciences 2022; 23(13): 6966 doi: 10.3390/ijms23136966
10
Koroush Ghanadi, Javad Valizadeh, Afshin Hasanvand. Epidemiological and clinical aspects of ulcerative colitis in west of Iran: a cross sectional studySpringerPlus 2016; 5(1) doi: 10.1186/s40064-016-3248-4
11
Susmita Mondal, Monojit Das, Ria Ghosh, Manali Singh, Aniruddha Adhikari, Soumendra Darbar, Anjan Kumar Das, Siddhartha Sankar Bhattacharya, Debasish Pal, Debasish Bhattacharyya, Ahmed S. A. Ahmed, Asim Kumar Mallick, Munirah M. Al-Rooqi, Ziad Moussa, Saleh A. Ahmed, Samir Kumar Pal. Chitosan functionalized Mn3O4 nanoparticles counteracts ulcerative colitis in mice through modulation of cellular redox stateCommunications Biology 2023; 6(1) doi: 10.1038/s42003-023-05023-6
12
Cortisone-loaded stearoyl ascorbic acid based nanostructured lipid carriers alleviate inflammatory changes in DSS-induced colitisBiomaterials Advances 2023; 148: 213383 doi: 10.1016/j.bioadv.2023.213383
13
Jia-Yan Nie, Qiu Zhao. Beverage consumption and risk of ulcerative colitisMedicine 2017; 96(49): e9070 doi: 10.1097/MD.0000000000009070
14
Eva Barreiro-Alonso, Cristina Saro-Gismera, Manuel Sánchez. Outcomes and prediction of corticosteroid therapy after successive courses of ulcerative colitis treatmentsExpert Review of Gastroenterology & Hepatology 2018; 12(7): 733 doi: 10.1080/17474124.2018.1489231
15
Zhenhuan Yang, Wenjing Liu, Xuefeng Zhou, Xiaoran Zhu, Feiya Suo, Shukun Yao. The effectiveness and safety of curcumin as a complementary therapy in inflammatory bowel diseaseMedicine 2020; 99(43): e22916 doi: 10.1097/MD.0000000000022916
16
Acharya Balkrishna, Rani Singh, Vivek Gohel, Sagar Arora, Rishabh Dev, Kunal Bhattacharya, Anurag Varshney. Enteric-Coated Cologrit Tablet Exhibit Robust Anti-Inflammatory Response in Ulcerative Colitis-like In-Vitro Models by Attuning NFκB-Centric Signaling AxisPharmaceuticals 2022; 16(1): 63 doi: 10.3390/ph16010063
17
Li-Hong Hu, Yu-Jing Fan, Qing Li, Jing-Ming Guan, Bo Qu, Feng-Hua Pei, Bing-Rong Liu. Bortezomib protects against dextran sulfate sodium-induced ulcerative colitis in miceMolecular Medicine Reports 2017; 15(6): 4093 doi: 10.3892/mmr.2017.6524
18
Heike E.F. Becker, John Penders, Daisy M.A. E. Jonkers. Microbial Metabolism of Inflammatory Bowel Disease Drugs: Current Evidence and Clinical ImplementationsGastroenterology 2022; 162(1): 4 doi: 10.1053/j.gastro.2021.07.050
19
Mariana Roque Coelho, Marcela Diogo Romi, Daniele Masterson Tavares Pereira Ferreira, Cyrla Zaltman, Marcia Soares-Mota. The Use of Curcumin as a Complementary Therapy in Ulcerative Colitis: A Systematic Review of Randomized Controlled Clinical TrialsNutrients 2020; 12(8): 2296 doi: 10.3390/nu12082296
20
Fan Wang, Juerong Feng, Qian Gao, Minxing Ma, Xue Lin, Jing Liu, Jin Li, Qiu Zhao. Carbohydrate and protein intake and risk of ulcerative colitis: Systematic review and dose-response meta-analysis of epidemiological studiesClinical Nutrition 2017; 36(5): 1259 doi: 10.1016/j.clnu.2016.10.009
21
Ling Zhao, Hai-tao Xiao, Huai-xue Mu, Tao Huang, Ze-si Lin, Linda Zhong, Guang-zhi Zeng, Bao-min Fan, Cheng-yuan Lin, Zhao-xiang Bian. Magnolol, a Natural Polyphenol, Attenuates Dextran Sulfate Sodium-Induced Colitis in MiceMolecules 2017; 22(7): 1218 doi: 10.3390/molecules22071218
22
Shihao Duan, Yi Yang, Yubin Cao, Pingrun Chen, Chang Liang, Yan Zhang. Symptoms of anxiety and depression associated with steroid efficacy and clinical outcomes in patients with inflammatory bowel diseaseFrontiers in Psychiatry 2023; 14 doi: 10.3389/fpsyt.2023.1029467